-
UBS Advisor Greg Mendoza Named to the Financial Times 401 Top Retirement Plan Advisors List
Post on 11/9/20
-
Magenta Therapeutics Appoints Steve Mahoney as Chief Financial and Operating Officer
Post on 11/9/20
-
Editas Medicine Appoints Lisa A. Michaels, M.D., as Chief Medical Officer
Post on 11/9/20
-
Inozyme Pharma Appoints Kevin B. Johnson, Ph.D., MBA, as Senior Vice President
Post on 11/9/20
-
BayCoast Bank Names Sonia Couto as Assistant Treasurer, Branch Manager
Post on 11/8/20
-
McCarter & English Elects Four Equity Partners
Post on 11/8/20
-
Norfield Development Partners Announce Executive Transition
Post on 11/6/20
-
CVS Health Appoints Karen S. Lynch as CEO
Post on 11/6/20
-
Suffolk Appoints Ralph Esposito as President
Post on 11/5/20
-
BayCoast Bank Promotes Filomena Lopes to Assistant Treasurer, Branch Manager
Post on 11/5/20
-
Dr. Steven O’Day Joins Agenus as Chief Medical Officer
Post on 11/5/20
-
Webster Promotes Jonathan Roberts to Lead Retail Banking and Consumer Lending
Post on 11/4/20
-
DPS Appoints Ryan McDonough, PE as Senior Vice President
Post on 11/4/20
-
Kevin Redmond Joins Fuseideas As Chief Creative Strategist
Post on 11/4/20
-
LogicBio Therapeutic Appoints Mariana Nacht, Ph.D., as Chief Scientific Officer
Post on 11/4/20
-
CNC Software Appoints Raf Lobato as European Sales Director
Post on 11/3/20
-
Syrinx Appoints Colin Reposa as President
Post on 11/3/20
-
Interview with Tony Gruebl, President of Think & Jeff Musgrove, MD of Executive Advisory and PE & Venture Support
Post on 11/3/20
-
Point Pickup Appoints Allen Arakal as COO
Post on 11/2/20
-
MIT Sloan Prof. Edward Roberts Receives the GCEC Legacy Award
Post on 11/2/20
-
Barnes Group Announces CFO Transition
Post on 11/2/20
-
Blueshift IP Founding Partners Cynthia Gilbert and Robert Plotkin Recognized as IP Trailblazers by National Law Journal
Post on 11/2/20
-
Elevate Counseling Services Names Kimberly Hollister of Plainville as Associate Director of Training Center
Post on 11/2/20
-
Myomo Appoints Dr. Harry Kovelman as Chief Medical Officer
Post on 11/2/20
-
X4 Pharmaceuticals Appoints Art Taveras, Ph.D., as Chief Scientific Officer
Post on 11/2/20
